Skip to main content
Premium Trial:

Request an Annual Quote

Transplant Genomics, Astellas to Collaborate on Kidney Transplant Study

NEW YORK (GenomeWeb) – Transplant Genomics (TGI) announced today that it has signed an agreement under which it will use its TruGraf post-kidney transplant blood test to evaluate renal transplant patient outcomes as part of a clinical trial being run by Astellas Pharma Global Development.

The two-year prospective, multi-center study is examining surrogate markers for long-term kidney outcomes — de novo donor-specific antibody (DSA) formation or a peripheral blood molecular phenotype of immune activation identified using the TruGraf test — in patients treated with either an immediate-release version of the immunosuppressive tacrolimus or Astellas's Astagraf XL (extended-release tacrolimus capsules).

These two markers will be combined as part of a dual composite endpoint to test the hypothesis that the consistency of immunosuppression with Astagraf XL decreases the development DSAs and lowers the molecular signature of immune activation, according to TGI.

TGI said Astellas will provide it with unspecified funding and blood samples from study participants for testing. Additional terms of the arrangement were not disclosed.

The deal with Astellas follows a similar agreement TGI signed last month to use TruGraf to evaluate patients in a Phase III trial of Quark Pharmaceuticals' RNAi-based treatment for delayed graft function QPI-1002.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.